Walgreens Boots Alliance (NASDAQ:WBA) Now Covered by StockNews.com

Equities researchers at StockNews.com assumed coverage on shares of Walgreens Boots Alliance (NASDAQ:WBA) in a note issued to investors on Tuesday. The firm set a “hold” rating on the pharmacy operator’s stock.

Other equities research analysts have also issued research reports about the stock. Truist Financial reduced their price objective on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating for the company in a research note on Friday, January 31st. Evercore ISI boosted their price target on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an “in-line” rating in a research report on Monday, January 13th. Royal Bank of Canada increased their price objective on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a “sector perform” rating in a report on Wednesday, January 15th. Bank of America boosted their target price on Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an “underperform” rating in a report on Monday, January 13th. Finally, Wolfe Research upgraded Walgreens Boots Alliance to a “hold” rating in a report on Monday, February 24th. Four equities research analysts have rated the stock with a sell rating, nine have given a hold rating and two have given a buy rating to the company. According to data from MarketBeat, Walgreens Boots Alliance currently has a consensus rating of “Hold” and an average target price of $11.54.

Walgreens Boots Alliance Stock Performance

Shares of NASDAQ WBA opened at $11.26 on Tuesday. Walgreens Boots Alliance has a one year low of $8.08 and a one year high of $22.05. The business’s 50-day moving average price is $10.86 and its two-hundred day moving average price is $9.77. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.64 and a quick ratio of 0.30. The company has a market capitalization of $9.73 billion, a P/E ratio of -1.10, a price-to-earnings-growth ratio of 1.31 and a beta of 0.62.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Friday, January 10th. The pharmacy operator reported $0.51 EPS for the quarter, beating the consensus estimate of $0.38 by $0.13. The business had revenue of $39.50 billion during the quarter, compared to analysts’ expectations of $37.40 billion. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The firm’s quarterly revenue was up 7.6% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.66 EPS. Analysts anticipate that Walgreens Boots Alliance will post 1.6 earnings per share for the current fiscal year.

Institutional Trading of Walgreens Boots Alliance

A number of hedge funds have recently modified their holdings of WBA. First Financial Corp IN raised its stake in shares of Walgreens Boots Alliance by 49.2% in the 4th quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator’s stock valued at $25,000 after buying an additional 885 shares in the last quarter. Golden State Wealth Management LLC bought a new stake in Walgreens Boots Alliance in the fourth quarter valued at about $26,000. Riverview Trust Co raised its position in Walgreens Boots Alliance by 123.8% in the fourth quarter. Riverview Trust Co now owns 2,874 shares of the pharmacy operator’s stock worth $27,000 after purchasing an additional 1,590 shares in the last quarter. Colonial Trust Co SC lifted its stake in Walgreens Boots Alliance by 79.5% during the fourth quarter. Colonial Trust Co SC now owns 2,928 shares of the pharmacy operator’s stock worth $27,000 after purchasing an additional 1,297 shares during the period. Finally, Venturi Wealth Management LLC acquired a new stake in Walgreens Boots Alliance during the fourth quarter valued at approximately $28,000. Institutional investors own 58.59% of the company’s stock.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.